Ledger.Open graph →
SEC Form D · filed July 15, 2009

Renavance Pharma, Inc

Offering
$500K
Sold
$500K
Exemption
—
Industry
Pharmaceuticals
Location
MILL VALLEY, CA
Type
—

People & firms on this filing (6)

Mark Kessel · New York, NYDirectorJohn Donovan · Mill Valley, CAExec · DirectorAndrew Busser · New York, NYDirectorPatrick Mccarty · Novato, CAExec · DirectorErick Kostuchek · Novato, CADirectorArthur Chatham · Novato, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗